search
Back to results

Case Series With Saneso 3600 Colonoscope

Primary Purpose

Colonic Neoplasms

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Colonoscopy
Sponsored by
Saneso Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Colonic Neoplasms focused on measuring Colonoscopy, Colonoscope

Eligibility Criteria

45 Years - 74 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • 45 -74 years of age Willing and able to comply with the study procedures and provide written informed consent to participate in the study.

Scheduled for a clinically indicated routine colonoscopy procedure ASA class 1-3.

Exclusion Criteria:

  • Altered colon anatomy Pregnant women, children under 18 years of age and adults over 75 years of age. Subjects for whom routine endoscopic procedures are contraindicated due to comorbid medical conditions.

Patients who are currently enrolled in another investigational study that would directly interfere with the current study, without prior written approval from the sponsor ASA class 4-5.

Sites / Locations

  • Valley Endoscopy Center
  • Wintersville Endoscopy Center, Wintersville
  • West Virginia University School of Medicine - Davis Medical Center
  • West Virginia University School of Medicine - Reynolds Memorial Hospital
  • West Virginia University School of Medicine - Reynolds Memorial Hospital,

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Study Arm Study device

Study Arm - Predicate Device

Arm Description

Patients who meet all eligibility criteria were included and had a clinically indicated colonoscopy procedure performed using the study device. Immediately thereafter, patients had a colonoscopy procedure using standard colonoscope (Olympus CF 180) by a second endoscopist.

Patients who meet all eligibility criteria were included and had a clinically indicated colonoscopy procedure performed using the study device. Immediately thereafter, patients had a colonoscopy procedure using standard colonoscope (Olympus CF 180) by a second endoscopist.

Outcomes

Primary Outcome Measures

Intubation of terminal ileum and cecum
Intubation of the terminal ileum and cecum

Secondary Outcome Measures

User feedback for operating characteristics of the device
User feedback for operating characteristics of the device

Full Information

First Posted
August 16, 2022
Last Updated
August 16, 2022
Sponsor
Saneso Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT05505370
Brief Title
Case Series With Saneso 3600 Colonoscope
Official Title
Case Series With Saneso 3600 Colonoscope
Study Type
Interventional

2. Study Status

Record Verification Date
August 2022
Overall Recruitment Status
Completed
Study Start Date
April 21, 2022 (Actual)
Primary Completion Date
July 15, 2022 (Actual)
Study Completion Date
July 31, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Saneso Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Saneso colonoscope is a novel FDA cleared colonoscope that provides a 360 degree integrated view of the colon. Saneso colonoscope has five cameras and multiple LED lights at the distal head. The objective of the present study is to evaluate clinical success of the Saneso colonoscope in intubation of the terminal ileum and to obtain user feedback with regards to usability characteristics compared to predicate devices.
Detailed Description
This study is a prospective, multi-center case series of per standard of care colonoscopy procedures using a nonsignificant risk Saneso 360 degree colonoscope. 40 cases were included at 3 clinical sites. Patients who meet all eligibility criteria were included and had a clinically indicated colonoscopy procedure performed using the study device. Immediately thereafter, patients had a colonoscopy procedure using standard colonoscope (Olympus CF 180) by a second endoscopist. Enrolled subjects were followed for 7 days after their procedure. If the procedure was not successful with the study device, the endoscopist completed the procedure with a traditional colonoscope used at each facility. This study was approved by the institutional review board of respective sites. The clinical trial was conducted in accordance with the standards of Good Clinical Practice (GCP) and in accordance with the principles of the Declaration of Helsinki.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colonic Neoplasms
Keywords
Colonoscopy, Colonoscope

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
The objective of the present study is to Study the clinical success and clinical safety of the Saneso colonoscope
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Study Arm Study device
Arm Type
Experimental
Arm Description
Patients who meet all eligibility criteria were included and had a clinically indicated colonoscopy procedure performed using the study device. Immediately thereafter, patients had a colonoscopy procedure using standard colonoscope (Olympus CF 180) by a second endoscopist.
Arm Title
Study Arm - Predicate Device
Arm Type
Active Comparator
Arm Description
Patients who meet all eligibility criteria were included and had a clinically indicated colonoscopy procedure performed using the study device. Immediately thereafter, patients had a colonoscopy procedure using standard colonoscope (Olympus CF 180) by a second endoscopist.
Intervention Type
Device
Intervention Name(s)
Colonoscopy
Intervention Description
Patients who meet all eligibility criteria were included and had a clinically indicated colonoscopy procedure performed using the study device. Immediately thereafter, patients had a colonoscopy procedure using standard colonoscope (Olympus CF 180) by a second endoscopist.
Primary Outcome Measure Information:
Title
Intubation of terminal ileum and cecum
Description
Intubation of the terminal ileum and cecum
Time Frame
4 months.
Secondary Outcome Measure Information:
Title
User feedback for operating characteristics of the device
Description
User feedback for operating characteristics of the device
Time Frame
4 months.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
45 Years
Maximum Age & Unit of Time
74 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: 45 -74 years of age Willing and able to comply with the study procedures and provide written informed consent to participate in the study. Scheduled for a clinically indicated routine colonoscopy procedure ASA class 1-3. Exclusion Criteria: Altered colon anatomy Pregnant women, children under 18 years of age and adults over 75 years of age. Subjects for whom routine endoscopic procedures are contraindicated due to comorbid medical conditions. Patients who are currently enrolled in another investigational study that would directly interfere with the current study, without prior written approval from the sponsor ASA class 4-5.
Facility Information:
Facility Name
Valley Endoscopy Center
City
Saint Clairsville
State/Province
Ohio
ZIP/Postal Code
43950
Country
United States
Facility Name
Wintersville Endoscopy Center, Wintersville
City
Wintersville
State/Province
Ohio
ZIP/Postal Code
43953
Country
United States
Facility Name
West Virginia University School of Medicine - Davis Medical Center
City
Elkins
State/Province
West Virginia
ZIP/Postal Code
26241
Country
United States
Facility Name
West Virginia University School of Medicine - Reynolds Memorial Hospital
City
Glendale
State/Province
West Virginia
ZIP/Postal Code
26038
Country
United States
Facility Name
West Virginia University School of Medicine - Reynolds Memorial Hospital,
City
Glendale
State/Province
West Virginia
ZIP/Postal Code
26506
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Case Series With Saneso 3600 Colonoscope

We'll reach out to this number within 24 hrs